Online Assessments Reveal a Common Subtype of Multiple Sclerosis with Hidden Cognitive Challenges

A groundbreaking study employing automated online assessments uncovers a prominent subtype of multiple sclerosis marked by hidden cognitive impairments despite minimal motor symptoms, highlighting the importance of digital tools in early detection and personalized treatment.
Recent research conducted by King's College London and Imperial College London, in collaboration with the UK MS Register, has identified a prevalent subtype of multiple sclerosis (MS) characterized by significant cognitive impairments despite minimal motor symptoms. This form of MS has traditionally gone unrecognized and untreated because typical evaluations emphasize physical disability, leaving cognitive deficits unnoticed.
Cognitive issues in MS are highly common, affecting between 40% and 70% of patients at various stages of the disease. These impairments often impact work ability and overall quality of life more profoundly than physical disabilities. However, standard neuropsychological tests are either lengthy or too narrowly focused, making routine assessment of cognition unfeasible in many settings. As a result, cognition is frequently excluded from disease phenotyping, leading to gaps in understanding its true prevalence and severity.
To address this challenge, researchers developed and deployed an automated online assessment tool to evaluate cognitive function across a large MS population. This approach aimed to identify distinct symptom-based MS phenotypes on a broad scale. The study involved 4,526 participants from the UK MS Register, who took part in three stages. The first stage tested 19,188 registrants with 22 online tasks designed to differentiate MS from other conditions. After analyzing effect sizes and device sensitivity, a core battery of 12 tasks was selected for further testing.
In the second stage, the 12-task battery was administered to a new cohort along with additional memory tasks, confirming the tool's ability to detect cognitive deficits. The third stage compared this online assessment with comprehensive in-person neuropsychological testing for 31 patients, further validating its effectiveness.
The online testing was user-friendly, with over 70% of participants completing the assessments in about 40 minutes. When combining online cognitive scores with motor function questionnaires, four distinct groups emerged:
- Minimal Motor Symptoms + Moderate Cognitive Impairment: Little movement difficulty but notable issues with memory, reasoning, and attention.
- Minimal Motor Symptoms + No Cognitive Impairment: Little movement difficulty and generally intact cognition, with only minor slowed performance on a single task.
- Severe Motor Symptoms + Mild Cognitive Problems: Significant movement issues with only mild cognitive difficulties.
- Severe Motor Symptoms + Severe Cognitive Impairment: Prominent movement issues alongside broad cognitive deficits.
Further comparison of the online tests with traditional clinic assessments showed strong agreement in cognitive classification, indicating that this automated approach can reliably detect the presence of cognitive impairment. Notably, the study revealed a common MS subtype characterized by weak motor symptoms but significant cognitive problems, which standard evaluations often miss.
This research underscores the potential of large-scale, automated online assessments to improve understanding of MS phenotypes and facilitate earlier, targeted interventions for cognitive issues that significantly affect daily life and disease management.
Source: https://medicalxpress.com/news/2025-09-online-uncovers-common-multiple-sclerosis.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
HHS Discontinues CDC Staff Responsible for Ensuring Safe Birth Control for Women with Medical Risks
The HHS has disbanded key CDC staff responsible for creating guidelines that ensure the safe use of contraception for women with underlying health conditions, raising concerns about reproductive health safety and future policy updates.
Does Semaglutide Really Impact Vision? What the Latest Research Shows
Recent research shows that semaglutide, a popular GLP-1 medication, is not definitively linked to eye disorders like diabetic retinopathy or vision loss. Learn more about the latest findings and what they mean for patients.
Innovative Computational Tool Unveils Hidden Cancer DNA Alterations That May Influence Treatment Resistance
A new computational tool from Mayo Clinic, BACDAC, uncovers hidden structural DNA changes in tumors, aiding prediction of treatment resistance and personalized therapy.
Native American Communities Face Medicaid Enrollment Challenges Amid New Work Requirements
Native American communities are at risk of healthcare coverage disruptions as new Medicaid work and eligibility requirements are implemented, highlighting ongoing procedural challenges and the importance of policy vigilance.